Institut de Pharmacologie Moléculaire et Cellulaire, UMR6097, CNRS et Université de Nice-Sophia-Antipolis, 660 Route des Lucioles, Sophia Antipolis, 06560 Valbonne, France.
J Biol Chem. 2011 Oct 21;286(42):36509-21. doi: 10.1074/jbc.M111.268540. Epub 2011 Aug 30.
Among mammalian secreted phospholipases A(2) (sPLA(2)s), group X sPLA(2) has the most potent hydrolyzing activity toward phosphatidylcholine and is involved in arachidonic acid (AA) release. Group X sPLA(2) is produced as a proenzyme and contains a short propeptide of 11 amino acids ending with a dibasic motif, suggesting cleavage by proprotein convertases. Although the removal of this propeptide is clearly required for enzymatic activity, the cellular location and the protease(s) involved in proenzyme conversion are unknown. Here we have analyzed the maturation of group X sPLA(2) in HEK293 cells, which have been extensively used to analyze sPLA(2)-induced AA release. Using recombinant mouse (PromGX) and human (ProhGX) proenzymes; HEK293 cells transfected with cDNAs coding for full-length ProhGX, PromGX, and propeptide mutants; and various permeable and non-permeable sPLA(2) inhibitors and protease inhibitors, we demonstrate that group X sPLA(2) is mainly converted intracellularly and releases AA before externalization from the cell. Most strikingly, the exogenous proenzyme does not elicit AA release, whereas the transfected proenzyme does elicit AA release in a way insensitive to non-permeable sPLA(2) inhibitors. In transfected cells, a permeable proprotein convertase inhibitor, but not a non-permeable one, prevents group X sPLA(2) maturation and partially blocks AA release. Mutations at the dibasic motif of the propeptide indicate that the last basic residue is required and sufficient for efficient maturation and AA release. All together, these results argue for the intracellular maturation of group X proenzyme in HEK293 cells by a furin-like proprotein convertase, leading to intracellular release of AA during secretion.
在哺乳动物分泌型磷脂酶 A2(sPLA2)中,X 组 sPLA2 对磷脂酰胆碱具有最强的水解活性,并参与花生四烯酸(AA)的释放。X 组 sPLA2 作为前体酶产生,含有 11 个氨基酸的短前肽,以双碱性基序结尾,提示其通过蛋白原转化酶切割。尽管该前肽的去除显然是酶活性所必需的,但前体酶转化涉及的细胞位置和蛋白酶尚不清楚。在这里,我们分析了 HEK293 细胞中 X 组 sPLA2 的成熟,该细胞已广泛用于分析 sPLA2 诱导的 AA 释放。使用重组小鼠(PromGX)和人(ProhGX)前酶;转染全长 ProhGX、PromGX 和前肽突变体 cDNA 的 HEK293 细胞;以及各种可渗透和不可渗透的 sPLA2 抑制剂和蛋白酶抑制剂,我们证明 X 组 sPLA2 主要在细胞内转化,并在从细胞外向细胞外释放 AA 之前释放 AA。最引人注目的是,外源性前酶不会引发 AA 释放,而转染的前酶会以对不可渗透的 sPLA2 抑制剂不敏感的方式引发 AA 释放。在转染的细胞中,一种可渗透的蛋白原转化酶抑制剂,但不是不可渗透的抑制剂,可阻止 X 组 sPLA2 的成熟并部分阻断 AA 的释放。前肽双碱性基序的突变表明,最后一个碱性残基是高效成熟和 AA 释放所必需和充分的。总而言之,这些结果表明在 HEK293 细胞中,X 组前体酶通过类枯草杆菌蛋白酶原转化酶在细胞内成熟,导致分泌过程中细胞内 AA 的释放。